IP Library Granted Patent US 9,758,775
Granted Patent B2
US 9,758,775 · App. 14/252,019 · Granted Sep 12, 2017

TAL effector-mediated DNA modification

Inventors: Daniel F. Voytas (Falcon Heights, MN); Adam J. Bogdanove (Ithaca, NY); Feng Zhang (Plymouth, MN)
Assignees: Regents of the University of Minnesota; Iowa State University Research Foundation, Inc.
C12N9/22C12N15/01C12N15/102C12N15/1082C12N15/62C12N15/63C12Y301/21004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,758,775
App. No.
14/252,019
Granted
Sep 12, 2017
Kind
B2
Abstract

Materials and Methods related to gene targeting (e.g., gene targeting with transcription activator-like effector nucleases; “TALENS”) are provided.

Claims (39)

1. A method for modifying the genetic material of a cell, comprising:

(a) providing a cell containing a target DNA sequence; and

(b) introducing a transcription activator-like (TAL) effector endonuclease into the cell, the TAL effector endonuclease comprising:

(i) a FokI endonuclease domain that can cleave double stranded DNA, and

(ii) a TAL effector domain comprising a plurality of TAL effector repeat sequences that, in combination, bind to a specific nucleotide sequence in the target DNA sequence,

such that the TAL effector endonuclease cleaves the target DNA sequence within or adjacent to the specific nucleotide sequence in the cell or progeny thereof.

2. The method of claim 1 , further comprising introducing into the cell a nucleic acid comprising a sequence homologous to at least a portion of the target DNA sequence, such that homologous recombination occurs between the target DNA sequence and the nucleic acid.

3. The method of claim 1 , wherein the cell is a eukaryotic cell.

4. The method of claim 1 , wherein the cell is a plant cell.

5. The method of claim 4 , wherein the plant cell is a protoplast.

6. The method of claim 1 , wherein the target DNA is chromosomal DNA.

7. The method of claim 1 , wherein the introducing comprises transfecting the cell with a nucleic acid encoding the TAL effector endonuclease.

8. The method of claim 1 , wherein the introducing comprises mechanically injecting the TAL effector endonuclease into the cell as a protein.

9. The method of claim 1 , wherein the introducing comprises delivering the TAL effector endonuclease into the cell as a protein by means of the bacterial type III secretion system.

10. The method of claim 1 , wherein the introducing comprises introducing the TAL effector endonuclease into the cell as a protein by electroporation.

11. The method of claim 1 , wherein the TAL effector domain that binds to a specific nucleotide sequence within the target DNA sequence comprises 15 or more DNA binding repeats.

12. The method of claim 11 , wherein each DNA binding repeat comprises a repeat variable-diresidue (RVD) that determines recognition of a base pair in the target DNA sequence, wherein each DNA binding repeat is responsible for recognizing one base pair in the target DNA sequence, and wherein the RVD comprises one or more of:

HD for recognizing C;

NG for recognizing T;

NI for recognizing A;

NN for recognizing G;

NS for recognizing A;

HG for recognizing T;

IG for recognizing T;

NK for recognizing G;

HA for recognizing C;

ND for recognizing C;

HI for recognizing C;

HN for recognizing G; and

NA for recognizing G.

13. A method for generating a genetically modified organism, comprising:

(a) providing a cell capable of generating an organism and containing a target DNA sequence in its genome;

(b) introducing a TAL effector endonuclease into the cell, the TAL effector endonuclease comprising:

(i) a FokI endonuclease domain that can cleave double stranded DNA, and

(ii) a TAL effector domain comprising a plurality of TAL effector repeat sequences that, in combination, bind to a specific nucleotide sequence in the target DNA sequence,

such that the TAL effector endonuclease cleaves the target DNA sequence within or adjacent to the specific nucleotide sequence in the cell, or progeny thereof, and introduces a genetic modification to the genome of the cell or progeny thereof; and

(c) generating a genetically modified organism from the cell or progeny resulting from step (b), wherein the organism comprises the genetic modification in its genome.

14. The method of claim 13 , wherein cell is a plant cell and the organism is a plant.

15. The method of claim 14 , wherein the method further comprises obtaining seeds from the plant.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 29, 2014
From: IOWA STATE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 034707/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2014
From: VOYTAS, DANIEL F.; ZHANG, FENG
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 033310/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2014
From: BOGDANOVE, ADAM J.
To: IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
Reel/Frame 033311/0626 →
Continuity (6)
Continuation 13738381 · Jan 10, 2013
Continuation 12965590 · Dec 10, 2010
Provisional Application 61285324 · Dec 10, 2009
Provisional Application 61352108 · Jun 7, 2010
Provisional Application 61366685 · Jul 22, 2010
Related Publication 20140335618A1 · Nov 13, 2014